The CDC recommends that all individuals aged 75 and older, as well as adults aged 60 and older who are at risk for severe RSV ...

Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...